Intracellular interaction of galectin-13 with the transcription factor HOXA1 does not seem to be exclusively important for embryonic development but also appears to be involved in cancer progression, since upregulation of HOXA1 is associated with a poor prognosis in patients with breast cancer or hepatocellular carcinoma [130, 131]. Here, HOXA1 is linked to cancer.